Literature DB >> 10445820

Immunolocalisation of vascular endothelial growth factor (VEGF) in human neonatal growth plate cartilage.

A Horner1, N J Bishop, S Bord, C Beeton, A W Kelsall, N Coleman, J E Compston.   

Abstract

Angiogenesis is essential for the replacement of cartilage by bone during growth and repair. In order to obtain a better understanding of the mechanisms regulating vascular invasion at sites of endochondral ossification we have investigated the expression of the endothelial cell-specific mitogen, vascular endothelial growth factor (VEGF), by chondrocytes in human neonatal growth plates. VEGF was absent from chondrocytes in the resting zone and only weakly expressed by occasional chondrocytes in the proliferating region. In the hypertrophic zone the number of chondrocytes stained and the intensity of staining for VEGF increased with chondrocyte hypertrophy, maximum expression of VEGF being observed in chondrocytes in the lower hypertrophic and mineralised regions of the cartilage. These observations provide the first demonstration of the presence of VEGF in situ in developing human bone and are consistent with in vitro observations demonstrating the upregulation of proangiogenic growth factor production with increasing chondrocyte hypertrophy. The presence of numerous small blood vessels and vascular structures in the subchondral region where VEGF expression was maximal indicates that VEGF produced by hypertrophic chondrocytes may play a key role in the regulation of vascular invasion of the growth plate.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10445820      PMCID: PMC1467951          DOI: 10.1046/j.1469-7580.1999.19440519.x

Source DB:  PubMed          Journal:  J Anat        ISSN: 0021-8782            Impact factor:   2.610


  31 in total

1.  A novel angiogenic molecule produced at the time of chondrocyte hypertrophy during endochondral bone formation.

Authors:  M Alini; A Marriott; T Chen; S Abe; A R Poole
Journal:  Dev Biol       Date:  1996-05-25       Impact factor: 3.582

2.  Molecular cloning of a novel vascular endothelial growth factor, VEGF-D.

Authors:  Y Yamada; J Nezu; M Shimane; Y Hirata
Journal:  Genomics       Date:  1997-06-15       Impact factor: 5.736

3.  Production of angiogenesis inhibitors and stimulators is modulated by cultured growth plate chondrocytes during in vitro differentiation: dependence on extracellular matrix assembly.

Authors:  F Descalzi Cancedda; A Melchiori; R Benelli; C Gentili; L Masiello; G Campanile; R Cancedda; A Albini
Journal:  Eur J Cell Biol       Date:  1995-01       Impact factor: 4.492

4.  Distribution of platelet-derived growth factor (PDGF) A chain mRNA, protein, and PDGF-alpha receptor in rapidly forming human bone.

Authors:  A Horner; S Bord; P Kemp; D Grainger; J E Compston
Journal:  Bone       Date:  1996-10       Impact factor: 4.398

5.  Comparison of VEGF, VEGF-B, VEGF-C and Ang-1 mRNA regulation by serum, growth factors, oncoproteins and hypoxia.

Authors:  B Enholm; K Paavonen; A Ristimäki; V Kumar; Y Gunji; J Klefstrom; L Kivinen; M Laiho; B Olofsson; V Joukov; U Eriksson; K Alitalo
Journal:  Oncogene       Date:  1997-05-22       Impact factor: 9.867

6.  A novel regulatory function of proteolytically cleaved VEGF-2 for vascular endothelial and smooth muscle cells.

Authors:  J S Hu; G A Hastings; S Cherry; R Gentz; S Ruben; T A Coleman
Journal:  FASEB J       Date:  1997-05       Impact factor: 5.191

7.  Cloning and characterization of a novel human gene related to vascular endothelial growth factor.

Authors:  S Grimmond; J Lagercrantz; C Drinkwater; G Silins; S Townson; P Pollock; D Gotley; E Carson; S Rakar; M Nordenskjöld; L Ward; N Hayward; G Weber
Journal:  Genome Res       Date:  1996-02       Impact factor: 9.043

8.  Induction of vascular endothelial growth factor by platelet-activating factor and platelet-derived growth factor is downregulated by corticosteroids.

Authors:  M Nauck; M Roth; M Tamm; O Eickelberg; H Wieland; P Stulz; A P Perruchoud
Journal:  Am J Respir Cell Mol Biol       Date:  1997-04       Impact factor: 6.914

9.  Purification of an angiogenesis inhibitor from culture medium conditioned by a human chondrosarcoma-derived chondrocytic cell line, HCS-2/8.

Authors:  Y Ohba; Y Goto; Y Kimura; F Suzuki; T Hisa; K Takahashi; M Takigawa
Journal:  Biochim Biophys Acta       Date:  1995-08-17

10.  Transferrin promotes endothelial cell migration and invasion: implication in cartilage neovascularization.

Authors:  M F Carlevaro; A Albini; D Ribatti; C Gentili; R Benelli; S Cermelli; R Cancedda; F D Cancedda
Journal:  J Cell Biol       Date:  1997-03-24       Impact factor: 10.539

View more
  19 in total

Review 1.  Contribution of endothelial cells to organogenesis: a modern reappraisal of an old Aristotelian concept.

Authors:  E Crivellato; B Nico; D Ribatti
Journal:  J Anat       Date:  2007-08-07       Impact factor: 2.610

2.  The dose of growth factors influences the synergistic effect of vascular endothelial growth factor on bone morphogenetic protein 4-induced ectopic bone formation.

Authors:  Guangheng Li; Karin Corsi-Payne; Bo Zheng; Arvydas Usas; Hairong Peng; Johnny Huard
Journal:  Tissue Eng Part A       Date:  2009-08       Impact factor: 3.845

3.  Regulation of vascular endothelial growth factor (VEGF) gene transcription by estrogen receptors alpha and beta.

Authors:  M D Mueller; J L Vigne; A Minchenko; D I Lebovic; D C Leitman; R N Taylor
Journal:  Proc Natl Acad Sci U S A       Date:  2000-09-26       Impact factor: 11.205

4.  Inhibition of prostate cancer osteoblastic progression with VEGF121/rGel, a single agent targeting osteoblasts, osteoclasts, and tumor neovasculature.

Authors:  Khalid A Mohamedali; Zhi Gang Li; Michael W Starbuck; Xinhai Wan; Jun Yang; Sehoon Kim; Wendy Zhang; Michael G Rosenblum; Nora M Navone
Journal:  Clin Cancer Res       Date:  2011-02-22       Impact factor: 12.531

5.  In vivo detection of human vascular endothelial growth factor promoter activity in transgenic mouse skin.

Authors:  J Kishimoto; R Ehama; Y Ge; T Kobayashi; T Nishiyama; M Detmar; R E Burgeson
Journal:  Am J Pathol       Date:  2000-07       Impact factor: 4.307

6.  Vascular endothelial growth factor plays an important autocrine/paracrine role in the progression of osteoarthritis.

Authors:  Eiji Tanaka; Junko Aoyama; Mutsumi Miyauchi; Takashi Takata; Koichi Hanaoka; Tatsunori Iwabe; Kazuo Tanne
Journal:  Histochem Cell Biol       Date:  2005-03-15       Impact factor: 4.304

7.  Expression of VEGF121 and VEGF165 in hypertrophic chondrocytes of the human growth plate and epiphyseal cartilage.

Authors:  Wolf Petersen; Michael Tsokos; Thomas Pufe
Journal:  J Anat       Date:  2002-08       Impact factor: 2.610

8.  Immunolocalization of vascular endothelial growth factor in rat condylar cartilage during postnatal development.

Authors:  Junko Aoyama; Eiji Tanaka; Mutsumi Miyauchi; Takashi Takata; Koichi Hanaoka; Yukiko Hattori; Akiko Sasaki; Mineo Watanabe; Kazuo Tanne
Journal:  Histochem Cell Biol       Date:  2004-07-01       Impact factor: 4.304

9.  Functional characterization of hypertrophy in chondrogenesis of human mesenchymal stem cells.

Authors:  Michael B Mueller; Rocky S Tuan
Journal:  Arthritis Rheum       Date:  2008-05

10.  Matrix vesicles are carriers of bone morphogenetic proteins (BMPs), vascular endothelial growth factor (VEGF), and noncollagenous matrix proteins.

Authors:  Niru N Nahar; Liliana R Missana; Rama Garimella; Sarah E Tague; H Clarke Anderson
Journal:  J Bone Miner Metab       Date:  2008-08-30       Impact factor: 2.626

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.